Jarushka Naidoo, Consultant Medical Oncologist at Beaumont RCSI Cancer Centre, shared a post on X:
“Best slides of WCLC25?
Daniel Tan’s elegant discussion of FLAURA2 in the context of the journey of EGFR+ NSCLC, incremental gains from sequential therapies, and the key factors informing decision making at clinical inflection points.”
More posts featuring Jarushka Naidoo.